If you've been using Zyrtec or Xyzal to combat your allergy symptoms this year, an FDA warning wants you to be aware of this ...

“Reported cases were rare but sometimes serious, with patients experiencing widespread, severe itching that required medical ...

Investigating allergy prevention, this research highlights early intervention strategies and the promise of biologic ...

Although the side effect is rare, the FDA said some patients experienced severe itching that required medical attention.

Some patients may suffer from unbearable itching across their entire body after stopping common allergy medications, health ...

The two antihistamines are approved for seasonal allergic rhinitis in individuals 2 years and up, along with perennial ...

The agency will require manufacturers to add a warning to prescription and OTC labeling about the risk of itching and the ...

According to these reports, pruritus developed days after discontinuing long-term daily treatment. Cases of pruritus have been reported in long-term users of cetirizine and levocetirizine ...

The patient’s medical history was significant for mild atopic dermatitis, well-controlled with triamcinolone ointment used ...

Rilzabrutinib is a promising treatment option for patients with chronic spontaneous urticaria who are refractory to antihistamines.

DelveInsight's Chronic Pruritus Market Insights report includes a comprehensive understanding of current treatment practices, chronic pruritus emerging drugs, market share of individual therapies, and ...

Two antihistamines, including Zyrtec, are under warning by the FDA after people reported “severe itching” after ceasing ...